|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Movva S, Rodriguez L, Arias-Pulido H and
Verschraegen C: Novel chemotherapy approaches for cervical cancer.
Cancer. 115:3166–3180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sittidilokratna K, Cheewakriangkrai C,
Khunamornpong S and Siriaunkgul S: Recurrence patterns after
radical hysterectomy in stage IB1-IIA cervical. Asian Pac J Cancer
Prev. 11:499–502. 2010.PubMed/NCBI
|
|
4
|
zur Hausen H: Papillomavirus infections-a
major cause of human cancers. Biochim Biophys Acta. 1288:F55–F78.
1996.PubMed/NCBI
|
|
5
|
de Sanjose S, Quint WG, Alemany L, Geraets
DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin
HR, et al: Retrospective international survey and HPV time trends
study group: Human papillomavirus genotype attribution in invasive
cervical cancer: a retrospective cross-sectional worldwide study.
Lancet Oncol. 11:1048–1056. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liao S, Deng D, Zhang W, Hu X, Wang W,
Wang H, Lu Y, Wang S, Meng L and Ma D: Human papillomavirus 16/18
E5 promotes cervical cancer cell proliferation, migration and
invasion in vitro and accelerates tumor growth in vivo. Oncol Rep.
29:95–102. 2013.
|
|
8
|
Chen H, Suo K, Cheng Y, Zheng B and Xu L:
Vascular endothelial growth factor C enhances cervical cancer
migration and invasion via activation of focal adhesion kinase.
Gynecol Endocrinol. 29:20–24. 2013. View Article : Google Scholar
|
|
9
|
Meng F, Zhao X and Zhang S: SHP-2
phosphatase promotes cervical cancer cell proliferation through
inhibiting interferon-β production. J Obstet Gynaecol Res.
39:272–279. 2013. View Article : Google Scholar
|
|
10
|
Wu Y, Zhou X and Zheng PS: Involvement of
CD147 isoform 4 in the proliferation of SiHa cells: A possible
molecular mechanism of cervical cancer. Oncol Rep. 26:717–724.
2011.PubMed/NCBI
|
|
11
|
Sun Y, Liu JH, Sui YX, Jin L, Yang Y, Lin
SM and Shi H: Beclin1 overexpression inhibitis proliferation,
invasion and migration of CaSki cervical cancer cells. Asian Pac J
Cancer Prev. 12:1269–1273. 2011.PubMed/NCBI
|
|
12
|
Song C, Zhu S, Wu C and Kang J: Histone
deacetylase (HDAC) 10 suppresses cervical cancer metastasis through
inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J
Biol Chem. 288:28021–28033. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siomi H and Siomi MC: Posttranscriptional
regulation of microRNA biogenesis in animals. Mol Cell. 38:323–332.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ,
Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, et al: Altered MicroRNA
expression in cervical carcinomas. Clin Cancer Res. 14:2535–2542.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lui WO, Pourmand N, Patterson BK and Fire
A: Patterns of known and novel small RNAs in human cervical cancer.
Cancer Res. 67:6031–6043. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pereira PM, Marques JP, Soares AR, Carreto
L and Santos MA: MicroRNA expression variability in human cervical
tissues. PLoS One. 5:e117802010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leung CO, Deng W, Ye TM, Ngan HY, Tsao SW,
Cheung AN, Pang RT and Yeung WS: miR-135a leads to cervical cancer
cell transformation through regulation of β-catenin via a SIAH1-
dependent ubiquitin proteosomal pathway. Carcinogenesis.
35:1931–1940. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Long MJ, Wu FX, Li P, Liu M, Li X and Tang
H: MicroRNA-10a targets CHL1 and promotes cell growth, migration
and invasion in human cervical cancer cells. Cancer Lett.
324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie H, Zhao Y, Caramuta S, Larsson C and
Lui WO: miR-205 expression promotes cell proliferation and
migration of human cervical cancer cells. PLoS One. 7:e469902012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu J, Wang Y, Dong R, Huang X, Ding S and
Qiu H: Circulating microRNA-218 was reduced in cervical cancer and
correlated with tumor invasion. J Cancer Res Clin Oncol.
138:671–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian RQ, Wang XH, Hou LJ, Jia WH, Yang Q,
Li YX, Liu M, Li X and Tang H: MicroRNA-372 is down-regulated and
targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human
cervical cancer, which may contribute to tumorigenesis. J Biol
Chem. 286:25556–25563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng RQ, Wan HY, Li HF, Liu M, Li X and
Tang H: MicroRNA-214 suppresses growth and invasiveness of cervical
cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:
polypeptide N-ace tylgalactosaminyltransferase 7. J Biol Chem.
287:14301–14309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu
K, Wei L and Chu M: The prognostic value of miR-21 and miR-155 in
non-small-cell lung cancer: A meta-analysis. Jpn J Clin Oncol.
43:813–820. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu ZL, Wang H, Liu J and Wang ZX:
MicroRNA-21 (miR-21) expression promotes growth, metastasis, and
chemo- or radiore-sistance in non-small cell lung cancer cells by
targeting PTEN. Mol Cell Biochem. 372:35–45. 2013. View Article : Google Scholar
|
|
25
|
Xiong B, Cheng Y, Ma L and Zhang C: miR-21
regulates biological behavior through the PTEN/PI-3 K/Akt signaling
pathway in human colorectal cancer cells. Int J Oncol. 42:219–228.
2013.
|
|
26
|
Liu S, Fang Y, Shen H, Xu W and Li H:
Berberine sensitizes ovarian cancer cells to cisplatin through
miR-21/PDCD4 axis. Acta Biochim Biophys Sin (Shanghai). 45:756–762.
2013. View Article : Google Scholar
|
|
27
|
Teng Y, Manavalan TT, Hu C, Medjakovic S,
Jungbauer A and Klinge CM: Endocrine disruptors fludioxonil and
fenhexamid stimulate miR-21 expression in breast cancer cells.
Toxicol Sci. 131:71–83. 2013. View Article : Google Scholar :
|
|
28
|
Alder H, Taccioli C, Chen H, Jiang Y,
Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, et
al: Dysregulation of miR-31 and miR-21 induced by zinc deficiency
promotes esophageal cancer. Carcinogenesis. 33:1736–1744. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deftereos G, Corrie SR, Feng Q, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
31
|
Chu EC and Tarnawski AS: PTEN regulatory
functions in tumor suppression and cell biology. Med Sci Monit.
10:RA235–RA241. 2004.PubMed/NCBI
|
|
32
|
Vázquez-Ulloa E, Lizano M, Avilés-Salas A,
Alfaro-Moreno E and Contreras-Paredes A: Abnormal distribution of
hDlg and PTEN in premalignant lesions and invasive cervical cancer.
Gynecol Oncol. 122:663–668. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsieh SM, Maguire DJ, Lintell NA, McCabe M
and Griffiths LR: PTEN and NDUFB8 aberrations in cervical cancer
tissue. Adv Exp Med Biol. 599:31–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sempere LF, Christensen M, Silahtaroglu A,
Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S and Cole CN:
Altered MicroRNA expression confined to specific epithelial cell
subpopulations in breast cancer. Cancer Res. 67:11612–11620. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar
|
|
39
|
Roldo C, Missiaglia E, Hagan JP, Falconi
M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, et
al: MicroRNA expression abnormalities in pancreatic endocrine and
acinar tumors are associated with distinctive pathologic features
and clinical behavior. J Clin Oncol. 24:4677–4684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sakai A, Thieblemont C, Wellmann A, Jaffe
ES and Raffeld M: PTEN gene alterations in lymphoid neoplasms.
Blood. 92:3410–3415. 1998.PubMed/NCBI
|
|
42
|
Tashiro H, Blazes MS, Wu R, Cho KR, Bose
S, Wang SI, Li J, Parsons R and Ellenson LH: Mutations in PTEN are
frequent in endometrial carcinoma but rare in other common
gynecological malignancies. Cancer Res. 57:3935–3940.
1997.PubMed/NCBI
|
|
43
|
Li DM and Sun H: TEP1, encoded by a
candidate tumor suppressor locus, is a novel protein tyrosine
phosphatase regulated by transforming growth factor beta. Cancer
Res. 57:2124–2129. 1997.PubMed/NCBI
|
|
44
|
Li L, Ernsting BR, Wishart MJ, Lohse DL
and Dixon JE: A family of putative tumor suppressors is
structurally and functionally conserved in humans and yeast. J Biol
Chem. 272:29403–29406. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Maehama T and Dixon JE: The tumor
suppressor, PTEN/MMAC1, dephosphorylates the lipid second
messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem.
273:13375–13378. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Harima Y, Sawada S, Nagata K, Sougawa M,
Ostapenko V and Ohnishi T: Mutation of the PTEN gene in advanced
cervical cancer correlated with tumor progression and poor outcome
after radiotherapy. Int J Oncol. 18:493–497. 2001.PubMed/NCBI
|
|
47
|
Odar K, Boštjančič E, Gale N, Glavač D and
Zidar N: Differential expression of microRNAs miR-21, miR-31,
miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in
verrucous carcinoma of the head and neck. Histopathology.
61:257–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
